BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 6852994)

  • 1. The efficacy of amiodarone for ventricular arrhythmias cannot be predicted with clinical electrophysiological studies.
    Waxman HL
    Int J Cardiol; 1983 Apr; 3(1):76-80. PubMed ID: 6852994
    [No Abstract]   [Full Text] [Related]  

  • 2. The efficacy of amiodarone for ventricular arrhythmias can be predicted with clinical electrophysiological studies.
    McGovern B; Ruskin JN
    Int J Cardiol; 1983 Apr; 3(1):71-6. PubMed ID: 6852993
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical pharmacology of amiodarone.
    Marcus FI
    Ann N Y Acad Sci; 1984; 427():112-26. PubMed ID: 6378011
    [No Abstract]   [Full Text] [Related]  

  • 4. Ventricular arrhythmias: use of electrophysiologic studies.
    Horowitz LN; Spielman SR; Greenspan AM; Webb CR; Kay HR
    Am Heart J; 1983 Oct; 106(4 Pt 2):881-6. PubMed ID: 6613834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiarrhythmic efficacy and electrophysiologic actions of amiodarone in patients with life-threatening ventricular arrhythmias: potent suppression of spontaneously occurring tachyarrhythmias versus inconsistent abolition of induced ventricular tachycardia.
    Nademanee K; Hendrickson J; Kannan R; Singh BN
    Am Heart J; 1982 Jun; 103(6):950-9. PubMed ID: 7081035
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical efficacy of amiodarone in treatment of recurrent ventricular tachycardia and ventricular fibrillation.
    Heger JJ; Prystowsky EN; Zipes DP
    Am Heart J; 1983 Oct; 106(4 Pt 2):887-94. PubMed ID: 6613835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Value of Holter monitoring in identifying risk for sustained ventricular arrhythmia recurrence on amiodarone.
    Marchlinski FE; Buxton AE; Flores BT; Doherty JU; Waxman HL; Josephson ME
    Am J Cardiol; 1985 Mar; 55(6):709-12. PubMed ID: 3976513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical experience with amiodarone for treatment of recurrent ventricular tachycardia and ventricular fibrillation.
    Heger JJ; Prystowsky EN; Miles WM; Zipes DP
    Br J Clin Pract Suppl; 1986 Apr; 44():16-27. PubMed ID: 3089256
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical efficacy of amiodarone as an antiarrhythmic agent.
    Rosenbaum MB; Chiale PA; Halpern MS; Nau GJ; Przybylski J; Levi RJ; Lázzari JO; Elizari MV
    Am J Cardiol; 1976 Dec; 38(7):934-44. PubMed ID: 793369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amiodarone for ventricular arrhythmias.
    N Engl J Med; 1981 Dec; 305(26):1587-9. PubMed ID: 7312002
    [No Abstract]   [Full Text] [Related]  

  • 11. Control of sudden recurrent arrhythmic deaths: role of amiodarone.
    Nademanee K; Singh BN; Cannom DS; Weiss J; Feld G; Stevenson WG
    Am Heart J; 1983 Oct; 106(4 Pt 2):895-901. PubMed ID: 6613836
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transient exacerbation followed by control of ventricular tachycardia with amiodarone.
    Mostow ND; Vrobel TR; Rakita L
    Am Heart J; 1986 Jan; 111(1):178-80. PubMed ID: 3946146
    [No Abstract]   [Full Text] [Related]  

  • 13. Antiarrhythmic actions of amiodarone.
    Anderson GJ
    Am Fam Physician; 1982 Apr; 25(4):178-80. PubMed ID: 6461234
    [No Abstract]   [Full Text] [Related]  

  • 14. Long-term clinical outcome of ventricular tachycardia or fibrillation treated with amiodarone.
    McGovern B; Garan H; Malacoff RF; DiMarco JP; Grant G; Sellers TD; Ruskin JN
    Am J Cardiol; 1984 Jun; 53(11):1558-63. PubMed ID: 6731300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Amiodarone in the treatment of disorders of cardiac rhythm. results of six years of clinical experience (author's transl)].
    Van Schepdael J; Solvay H
    Schweiz Rundsch Med Prax; 1975 Jan; 64(2):30-4. PubMed ID: 56002
    [No Abstract]   [Full Text] [Related]  

  • 16. Amiodarone: clinical efficacy and toxicity in 96 patients with recurrent, drug-refractory arrhythmias.
    Fogoros RN; Anderson KP; Winkle RA; Swerdlow CD; Mason JW
    Circulation; 1983 Jul; 68(1):88-94. PubMed ID: 6851057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical efficacy and electrophysiology during long-term therapy for recurrent ventricular tachycardia or ventricular fibrillation.
    Heger JJ; Prystowsky EN; Jackman WM; Naccarelli GV; Warfel KA; Rinkenberger RL; Zipes DP
    N Engl J Med; 1981 Sep; 305(10):539-45. PubMed ID: 6789201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. QT prolongation and the antiarrhythmic efficacy of amiodarone.
    Torres V; Tepper D; Flowers D; Wynn J; Lam S; Keefe D; Miura DS; Somberg JC
    J Am Coll Cardiol; 1986 Jan; 7(1):142-7. PubMed ID: 3941202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Causes and treatment of ventricular arrhythmias].
    Kappenberger L
    Schweiz Med Wochenschr; 1990 Jun; 120(25):941-5. PubMed ID: 1695020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ventricular flutter during treatment with amiodarone.
    Cui G; Huang W; Urthaler F
    Am J Cardiol; 1983 Feb; 51(3):609-10. PubMed ID: 6823876
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.